|
US4670190A
(en)
*
|
1973-01-10 |
1987-06-02 |
Hesse Robert H |
1-α-hydroxy vitamin D compounds and process for preparing same
|
|
US3932634A
(en)
*
|
1973-06-28 |
1976-01-13 |
Pfizer Inc. |
High potency vitamin water dispersible formulations
|
|
DE2526938C2
(de)
*
|
1975-02-14 |
1982-04-22 |
F. Hoffmann-La Roche & Co. AG, 4002 Basel |
Vitaminpräparate
|
|
US4217344A
(en)
*
|
1976-06-23 |
1980-08-12 |
L'oreal |
Compositions containing aqueous dispersions of lipid spheres
|
|
US4225596A
(en)
*
|
1978-10-13 |
1980-09-30 |
Wisconsin Alumni Research Foundation |
Method for treating calcium imbalance and improving calcium absorption in mammals
|
|
US4234495A
(en)
*
|
1979-09-10 |
1980-11-18 |
Wisconsin Alumni Research Foundation |
Process for preparing 1α-hydroxyvitamin D compounds from 1α-hydroxy-3,5-cyclovitamin D compounds
|
|
US4308264A
(en)
*
|
1981-01-28 |
1981-12-29 |
Abbott Laboratories |
Stabilized, dilute aqueous preparation of 1α,25-dihydroxycholecalciferol for neonatal administration
|
|
JPS57149224A
(en)
*
|
1981-03-13 |
1982-09-14 |
Chugai Pharmaceut Co Ltd |
Tumor-suppressing agent
|
|
JPS58210010A
(ja)
*
|
1982-05-31 |
1983-12-07 |
Kureha Chem Ind Co Ltd |
抗腫瘍剤
|
|
US4727064A
(en)
*
|
1984-04-25 |
1988-02-23 |
The United States Of America As Represented By The Department Of Health And Human Services |
Pharmaceutical preparations containing cyclodextrin derivatives
|
|
US4866048A
(en)
*
|
1985-08-02 |
1989-09-12 |
Leo Pharmaceutical Products Ltd. |
Novel vitamin D analogues
|
|
US5023271A
(en)
*
|
1985-08-13 |
1991-06-11 |
California Biotechnology Inc. |
Pharmaceutical microemulsions
|
|
JPS62149619A
(ja)
*
|
1985-09-05 |
1987-07-03 |
Teijin Ltd |
活性型ビタミンｄ３類注射用組成物
|
|
US4816247A
(en)
*
|
1985-09-11 |
1989-03-28 |
American Cyanamid Company |
Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs
|
|
US4784845A
(en)
*
|
1985-09-16 |
1988-11-15 |
American Cyanamid Company |
Emulsion compostions for the parenteral administration of sparingly water soluble ionizable hydrophobic drugs
|
|
US4877778A
(en)
*
|
1987-07-01 |
1989-10-31 |
The Children's Medical Center Corporation |
Method of enhancing lipophile transport using cyclodextrin derivatives
|
|
US5229422A
(en)
*
|
1987-09-07 |
1993-07-20 |
Teijin Limited |
Extemporaneous preparation type kit of a pharmaceutical substance-containing fat emulsion
|
|
US5342625A
(en)
*
|
1988-09-16 |
1994-08-30 |
Sandoz Ltd. |
Pharmaceutical compositions comprising cyclosporins
|
|
EP0390930B1
(de)
*
|
1988-09-26 |
1993-03-03 |
Teijin Limited |
Stabile wässrige zubereitung von aktivem vitamin-d-3
|
|
JP2525478B2
(ja)
*
|
1989-03-01 |
1996-08-21 |
帝人株式会社 |
安定性の改良された活性型ビタミンｄ▲下３▼類固型製剤
|
|
US5085864A
(en)
*
|
1989-10-30 |
1992-02-04 |
Abbott Laboratories |
Injectable formulation for lipophilic drugs
|
|
KR0166088B1
(ko)
*
|
1990-01-23 |
1999-01-15 |
. |
수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
|
|
FR2657526B1
(fr)
*
|
1990-01-31 |
1994-10-28 |
Lvmh Rech |
Utilisation d'un phosphate d'alpha-tocopherol, ou de l'un de ses derives, pour la preparation de compositions cosmetiques, dermatologiques, ou pharmaceutiques; compositions ainsi obtenues.
|
|
US5260290A
(en)
*
|
1990-02-14 |
1993-11-09 |
Wisconsin Alumni Research Foundation |
Homologated vitamin D2 compounds and the corresponding 1α-hydroxylated derivatives
|
|
JP3201411B2
(ja)
*
|
1990-06-15 |
2001-08-20 |
メルシャン株式会社 |
ビタミンｄ類の生物学的製造方法
|
|
US5120720A
(en)
*
|
1990-09-20 |
1992-06-09 |
The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services |
Preparation of lipophile:hydroxypropylcyclodextrin complexes by a method using co-solubilizers
|
|
US5763428A
(en)
*
|
1990-09-21 |
1998-06-09 |
Bone Care International, Inc. |
Methods of treating skin disorders with novel 1a-hydroxy vitamin D4 compounds and derivatives thereof
|
|
US6538037B2
(en)
*
|
1991-01-08 |
2003-03-25 |
Bone Care International, Inc. |
Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
|
|
US20040009958A1
(en)
*
|
1991-01-08 |
2004-01-15 |
Bone Care International, Inc. |
Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2
|
|
US5298246A
(en)
*
|
1991-01-09 |
1994-03-29 |
Kanegafuchi Kagaku Kogyo Kabushiki Kaisha |
Stable pharmaceutical composition and method for its production
|
|
DK0508756T3
(da)
*
|
1991-04-09 |
1997-03-24 |
Takeda Chemical Industries Ltd |
Stabiliseret vitamin D-præparat
|
|
US5502224A
(en)
*
|
1991-06-04 |
1996-03-26 |
Marigen, S.A. |
Biotenside esters and phosphatides with vitamin-D and vitamin-E compounds
|
|
US5486509A
(en)
*
|
1991-06-28 |
1996-01-23 |
University Of Miami |
Method of preventing and treating chemotherapy-induced alopecia
|
|
US5795882A
(en)
*
|
1992-06-22 |
1998-08-18 |
Bone Care International, Inc. |
Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
|
|
ES2170069T3
(es)
*
|
1992-06-22 |
2002-08-01 |
Bone Care Int Inc |
1-alfa-hidroxiprevitamina d para administracion oral.
|
|
CA2096105A1
(en)
*
|
1992-10-07 |
1994-04-08 |
Enrico Giuseppe Baggiolini (Deceased) |
Vitamin d3 fluorinated analogs
|
|
US5350745A
(en)
*
|
1993-01-29 |
1994-09-27 |
Lunar Corporation |
Treatment of myocardial failure
|
|
DK0667166T3
(da)
*
|
1993-09-01 |
2000-10-16 |
Teijin Ltd |
Emulsionspræparat med 1alpha, 24-(OH)2-vitamin D3
|
|
US5763429A
(en)
*
|
1993-09-10 |
1998-06-09 |
Bone Care International, Inc. |
Method of treating prostatic diseases using active vitamin D analogues
|
|
US6054136A
(en)
*
|
1993-09-30 |
2000-04-25 |
Gattefosse S.A. |
Orally administrable composition capable of providing enhanced bioavailability when ingested
|
|
US6312704B1
(en)
*
|
1993-09-30 |
2001-11-06 |
Gattefosse, S.A. |
Orally administrable composition capable of providing enhanced bioavailability when ingested
|
|
GB9405304D0
(en)
*
|
1994-03-16 |
1994-04-27 |
Scherer Ltd R P |
Delivery systems for hydrophobic drugs
|
|
EP0788346B9
(de)
*
|
1994-03-18 |
2007-02-14 |
Supernus Pharmaceuticals, Inc. |
Emulgierte arzneistoffabgabesysteme
|
|
CA2122431C
(en)
*
|
1994-04-28 |
2006-10-10 |
Reinhold W. Vieth |
Topical administration of vitamin d to mammals and compositions therefor
|
|
GB9409778D0
(en)
*
|
1994-05-16 |
1994-07-06 |
Dumex Ltd As |
Compositions
|
|
US5932544A
(en)
*
|
1994-05-31 |
1999-08-03 |
Xoma Corporation |
Bactericidal/permeability-increasing protein (BPI) compositions
|
|
US5597575A
(en)
*
|
1994-06-06 |
1997-01-28 |
Breitbarth; Richard |
Composition for stimulating and inducing hair growth
|
|
US20040043971A1
(en)
*
|
1995-04-03 |
2004-03-04 |
Bone Care International, Inc. |
Method of treating and preventing hyperparathyroidism with active vitamin D analogs
|
|
US20020183288A1
(en)
*
|
1995-04-03 |
2002-12-05 |
Bone Care International, Inc. |
Method for treating and preventing hyperparathyroidism
|
|
US6242434B1
(en)
*
|
1997-08-08 |
2001-06-05 |
Bone Care International, Inc. |
24-hydroxyvitamin D, analogs and uses thereof
|
|
EP0771789B1
(de)
*
|
1995-10-30 |
2000-02-16 |
F. Hoffmann-La Roche Ag |
1-Alpha, 26-dihydroxy-D-homo-vitamin D3
|
|
US6730679B1
(en)
*
|
1996-03-22 |
2004-05-04 |
Smithkline Beecham Corporation |
Pharmaceutical formulations
|
|
US5993858A
(en)
*
|
1996-06-14 |
1999-11-30 |
Port Systems L.L.C. |
Method and formulation for increasing the bioavailability of poorly water-soluble drugs
|
|
US5891469A
(en)
*
|
1997-04-02 |
1999-04-06 |
Pharmos Corporation |
Solid Coprecipitates for enhanced bioavailability of lipophilic substances
|
|
US6034074A
(en)
*
|
1996-09-13 |
2000-03-07 |
New Life Pharmaceuticals Inc. |
Prevention of ovarian cancer by administration of a Vitamin D compound
|
|
US6566353B2
(en)
*
|
1996-12-30 |
2003-05-20 |
Bone Care International, Inc. |
Method of treating malignancy associated hypercalcemia using active vitamin D analogues
|
|
US6573256B2
(en)
*
|
1996-12-30 |
2003-06-03 |
Bone Care International, Inc. |
Method of inhibiting angiogenesis using active vitamin D analogues
|
|
US6503893B2
(en)
*
|
1996-12-30 |
2003-01-07 |
Bone Care International, Inc. |
Method of treating hyperproliferative diseases using active vitamin D analogues
|
|
US20020128240A1
(en)
*
|
1996-12-30 |
2002-09-12 |
Bone Care International, Inc. |
Treatment of hyperproliferative diseases using active vitamin D analogues
|
|
US6458373B1
(en)
*
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
|
NZ336924A
(en)
*
|
1997-02-13 |
2001-06-29 |
Bone Care Int Inc |
Targeted therapeutic delivery of vitamin D compounds via a Vitamin D conjugate
|
|
US20030129194A1
(en)
*
|
1997-02-13 |
2003-07-10 |
Bone Care International, Inc. |
Targeted therapeutic delivery of vitamin D compounds
|
|
US6537561B1
(en)
*
|
1997-02-27 |
2003-03-25 |
Nippon Shinyaku Co., Ltd. |
Fat emulsion for oral administration
|
|
US6426078B1
(en)
*
|
1997-03-17 |
2002-07-30 |
Roche Vitamins Inc. |
Oil in water microemulsion
|
|
US6046177A
(en)
*
|
1997-05-05 |
2000-04-04 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
|
|
US5874418A
(en)
*
|
1997-05-05 |
1999-02-23 |
Cydex, Inc. |
Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
|
|
US6372234B1
(en)
*
|
1997-05-27 |
2002-04-16 |
Sembiosys Genetics Inc. |
Products for topical applications comprising oil bodies
|
|
US6599513B2
(en)
*
|
1997-05-27 |
2003-07-29 |
Sembiosys Genetics Inc. |
Products for topical applications comprising oil bodies
|
|
US20030044434A1
(en)
*
|
1997-07-29 |
2003-03-06 |
Ping Gao |
Self-emulsifying formulation for lipophilic compounds
|
|
KR100509130B1
(ko)
*
|
1997-07-29 |
2005-08-18 |
파마시아 앤드 업존 캄파니 엘엘씨 |
친지성 화합물의 자가유화 제제
|
|
US6087350A
(en)
*
|
1997-08-29 |
2000-07-11 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Use of pretreatment chemicals to enhance efficacy of cytotoxic agents
|
|
US5919986A
(en)
*
|
1997-10-17 |
1999-07-06 |
Hoffmann-La Roche Inc. |
D-homo vitamin D3 derivatives
|
|
CA2326117A1
(en)
*
|
1998-03-27 |
1999-10-07 |
Oregon Health Sciences University |
Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders
|
|
US6277061B1
(en)
*
|
1998-03-31 |
2001-08-21 |
The Research Foundation Of State University Of New York |
Method of inhibiting membrane-type matrix metalloproteinase
|
|
US6136799A
(en)
*
|
1998-04-08 |
2000-10-24 |
Abbott Laboratories |
Cosolvent formulations
|
|
US5972917A
(en)
*
|
1998-05-29 |
1999-10-26 |
Bone Care Int Inc |
1 α-hydroxy-25-ene-vitamin D, analogs and uses thereof
|
|
US6241969B1
(en)
*
|
1998-06-26 |
2001-06-05 |
Elan Corporation Plc |
Aqueous compositions containing corticosteroids for nasal and pulmonary delivery
|
|
US6552009B2
(en)
*
|
1998-07-16 |
2003-04-22 |
Gentrix Llc |
Compositions and methods of treating abnormal cell proliferation
|
|
US20010002396A1
(en)
*
|
1998-07-16 |
2001-05-31 |
Charles Achkar |
Compositions and methods of treating skin conditions
|
|
EP2127642A3
(de)
*
|
1998-08-13 |
2010-02-24 |
Cima Labs, Inc. |
Mikroemulsionen als feste Dosisformen zur oralen Verabreichung
|
|
US6218430B1
(en)
*
|
1998-08-24 |
2001-04-17 |
Ligand Pharmaceuticals Incorporated |
Vitamin D3 mimics
|
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
|
CA2348235A1
(en)
*
|
1998-10-23 |
2000-05-04 |
Teijin Limited |
Vitamin d3 derivatives and treating agent for inflammatory respiratory disease using same
|
|
FR2785284B1
(fr)
*
|
1998-11-02 |
2000-12-01 |
Galderma Res & Dev |
Analogues de la vitamine d
|
|
US6267985B1
(en)
*
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
|
US20030104048A1
(en)
*
|
1999-02-26 |
2003-06-05 |
Lipocine, Inc. |
Pharmaceutical dosage forms for highly hydrophilic materials
|
|
US6294192B1
(en)
*
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
|
US6248363B1
(en)
*
|
1999-11-23 |
2001-06-19 |
Lipocine, Inc. |
Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
|
|
US6270806B1
(en)
*
|
1999-03-03 |
2001-08-07 |
Elan Pharma International Limited |
Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions
|
|
US6204288B1
(en)
*
|
1999-03-08 |
2001-03-20 |
The University Of Mississippi |
1,2-dithiolane derivatives
|
|
US6045826A
(en)
*
|
1999-04-02 |
2000-04-04 |
National Research Council Of Canada |
Water-soluble compositions of bioactive lipophilic compounds
|
|
US6372251B2
(en)
*
|
1999-06-11 |
2002-04-16 |
Abbott Laboratories |
Formulations comprising lipid-regulating agents
|
|
US6524594B1
(en)
*
|
1999-06-23 |
2003-02-25 |
Johnson & Johnson Consumer Companies, Inc. |
Foaming oil gel compositions
|
|
US6309663B1
(en)
*
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
|
ES2228557T3
(es)
*
|
1999-07-16 |
2005-04-16 |
Leo Pharma A/S |
Aminobenzofenonas con inhibidores de la il-1beta y tnf-alfa.
|
|
US6274169B1
(en)
*
|
1999-08-02 |
2001-08-14 |
Abbott Laboratories |
Low oxygen content compostions of 1α, 25-dihydroxycholecalciferol
|
|
US6051567A
(en)
*
|
1999-08-02 |
2000-04-18 |
Abbott Laboratories |
Low oxygen content compositions of 1α, 25-dihydroxycholecalciferol
|
|
US6211169B1
(en)
*
|
1999-09-29 |
2001-04-03 |
Aesgen, Inc. |
Stable calcitriol solution for packaging into vials
|
|
AU7995300A
(en)
*
|
1999-10-05 |
2001-05-10 |
Bethesda Pharmaceuticals, Inc. |
Dithiolane derivatives
|
|
SK8562002A3
(en)
*
|
1999-12-23 |
2003-10-07 |
Pfizer Prod Inc |
Pharmaceutical compositions providing enhanced drug concentrations
|
|
EP1265496B1
(de)
*
|
2000-03-24 |
2005-11-02 |
Adisseo France S.A.S. |
Flüssige vitaminzubereitung
|
|
JP2004504295A
(ja)
*
|
2000-07-18 |
2004-02-12 |
ボーン ケア インターナショナル インコーポレイテッド |
安定化１α−ヒドロキシビタミンＤ
|
|
DE10036871A1
(de)
*
|
2000-07-28 |
2002-02-14 |
Pharmasol Gmbh |
Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
|
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US20030191093A1
(en)
*
|
2001-12-03 |
2003-10-09 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
|
US20040058895A1
(en)
*
|
2002-09-18 |
2004-03-25 |
Bone Care International, Inc. |
Multi-use vessels for vitamin D formulations
|
|
US20040053895A1
(en)
*
|
2002-09-18 |
2004-03-18 |
Bone Care International, Inc. |
Multi-use vessels for vitamin D formulations
|
|
US7148211B2
(en)
*
|
2002-09-18 |
2006-12-12 |
Genzyme Corporation |
Formulation for lipophilic agents
|
|
US20050101576A1
(en)
*
|
2003-11-06 |
2005-05-12 |
Novacea, Inc. |
Methods of using vitamin D compounds in the treatment of myelodysplastic syndromes
|
|
WO2004047673A2
(en)
*
|
2002-11-21 |
2004-06-10 |
Novacea, Inc. |
Treatment of liver disease with active vitamin d compounds
|
|
US20050026877A1
(en)
*
|
2002-12-03 |
2005-02-03 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
|
EP1631297A4
(de)
*
|
2003-06-11 |
2007-09-05 |
Novacea Inc |
Behandlung von immunvermittelten erkrankungen mit aktiven vitamin d verbindungen allein oder in kombination mit anderen therapeutika
|
|
US20060189586A1
(en)
*
|
2003-06-11 |
2006-08-24 |
Cleland Jeffrey L |
Pharmaceutical compositions comprising active vitamin D compounds
|
|
AU2004265238A1
(en)
*
|
2003-06-11 |
2005-02-24 |
Novacea, Inc. |
Treatment of lung cancer with active vitamin D compounds in combination with other treatments
|
|
US20050020546A1
(en)
*
|
2003-06-11 |
2005-01-27 |
Novacea, Inc. |
Pharmaceutical compositions comprising active vitamin D compounds
|
|
CA2528359A1
(en)
*
|
2003-06-11 |
2004-12-23 |
Novacea, Inc. |
Treatment of cancer with active vitamin d compounds in combination with radiotherapeutic agents and treatments
|
|
JP2007537263A
(ja)
*
|
2004-05-10 |
2007-12-20 |
ノバセア インコーポレイティッド |
活性ビタミンｄ化合物による動脈再狭窄の予防法
|
|
US20070275934A1
(en)
*
|
2004-05-10 |
2007-11-29 |
Curd John G |
Treatment of pancreatic cancer with active vitamin d compounds in combination with other treatments
|
|
US20080069814A1
(en)
*
|
2005-01-05 |
2008-03-20 |
Novacea, Inc. |
Prevention of Thrombotic Disorders with Active Vitamin D Compounds or Mimics Thereof
|
|
EP1833485A2
(de)
*
|
2005-01-05 |
2007-09-19 |
Novacea, Inc. |
Verhinderung thrombotischer erkrankungen durch aktive vitamin-d-verbindungen oder mimetika davon
|
|
US20090069276A1
(en)
*
|
2005-04-22 |
2009-03-12 |
Novacea, Inc. |
Treatment, prevention and amelioration of pulmonary disorders associated with chemotherapy or radiotherapy with active vitamin D compounds or mimics thereof
|
|
JP2009513567A
(ja)
*
|
2005-09-26 |
2009-04-02 |
ノバセア インコーポレイティッド |
活性ビタミンｄ化合物を用いた化学療法又は放射線療法に関連する胃腸及び膀胱の疾患の予防及び治療
|